Blog/Education
Education

Adderall vs Vyvanse: How the Two ADHD Medications Differ

RO

Rize OC

Editorial Team

November 9, 2026
9 min read
Adderall vs VyvanseADHD medicationlisdexamfetaminestimulant medicationadult ADHDprescriber questions
Adderall vs Vyvanse: How the Two ADHD Medications Differ

Adderall vs Vyvanse comes down to one real difference: Adderall contains mixed amphetamine salts that are active when you swallow them, while Vyvanse contains lisdexamfetamine, which your body has to convert into active amphetamine. Both are schedule II stimulants approved for ADHD, and the FDA labels describe different release and misuse details worth reading before your appointment.

Adderall vs Vyvanse at a glance: what the FDA labels say

The FDA labels for both medicines list ADHD as an approved use, and both carry the same schedule II classification from the DEA, the category for drugs with a high potential for misuse. Beyond that, the labels diverge on what the product contains and how it reaches your bloodstream. The table below sticks to what the labels state, so you can bring it to your appointment.

| | Adderall | Vyvanse | |---|---|---| | Active ingredient | Mixed amphetamine salts (dextroamphetamine and amphetamine) | Lisdexamfetamine dimesylate | | Release form | Immediate-release tablets; a separate extended-release capsule version (Adderall XR) | Capsules and chewable tablets | | Schedule | Schedule II | Schedule II | | Approved uses | ADHD and narcolepsy | ADHD and moderate to severe binge eating disorder in adults |

You can read the full prescribing information for each product on the FDA's Drugs@FDA database, which is the source for every row above.

Two details in the table tend to surprise people. Adderall comes in more than one release form, so "Adderall" at your pharmacy could mean a short-acting tablet or an extended-release capsule, and your prescriber can tell you which one you'd be comparing. Vyvanse's extra approved use for binge eating disorder doesn't change how it's prescribed for ADHD, but it explains why the label includes that language.

When you read the labels yourself, look at the sections on warnings, adverse reactions, and drug interactions. Write down anything that doesn't match your health history or the other medicines you take, and bring those notes with you.

How Vyvanse's prodrug design changes release in the body

Vyvanse is a prodrug, so the capsule or chewable tablet holds lisdexamfetamine, an inactive compound your body has to convert before it works as a stimulant. According to the FDA prescribing information for Vyvanse, the conversion happens after the medicine is absorbed, and the product releases active dextroamphetamine into the blood. Adderall's mixed amphetamine salts are already active when you swallow them, so the tablet skips that extra step.

The practical effect is on timing. Because Vyvanse has to be converted first, the label describes a gradual rise in active drug rather than an immediate one. Adderall's immediate-release tablets are absorbed directly. Adderall XR, the extended-release capsule, is designed to release the drug over a longer stretch, so the closer comparison for many people is Vyvanse against Adderall XR, not against the short-acting tablet.

Your prescriber can explain what that timing means for your own day, such as when you'd take a dose and how long you might notice it working. Those details depend on the specific product, and the label is the place to confirm them.

The label explains how the drug is made but not how it will feel for you, so a few questions are worth bringing along. Ask whether your prescriber is comparing Vyvanse with the immediate-release tablet or with Adderall XR, and how a dose would fit around your work hours and sleep. Also ask whether any other medicine you take could change how your body handles either product.

Your pharmacist can answer questions about the chewable tablet versus the capsule, and about how each should be taken. Keep those instructions from your prescriber and the label, and don't adjust anything on your own.

Side effects listed in each FDA label

The two labels share most of their warnings, because both products deliver amphetamine. Each label carries a boxed warning about abuse, misuse, and addiction, and each lists cardiovascular effects, blood pressure and heart rate increases, new or worsening psychiatric symptoms, and slowed growth in children as areas for monitoring. Adults get the same core cautions from either product, and you can find them under "Warnings and Precautions" in the FDA prescribing information.

The "Adverse Reactions" sections also overlap. Both labels name decreased appetite, trouble sleeping, dry mouth, and anxiety or irritability among the common reactions in adults. Vyvanse's label also lists nausea, diarrhea, and feeling jittery, while Adderall's describes reactions such as headache, stomach pain, and mood changes. The labels draw these from separate clinical trials with different designs, so the lists can't be read as a ranking of which one is gentler.

Some effects call for a prompt call to your prescriber rather than waiting for your next visit. These include chest pain, a racing or pounding heartbeat, fainting, shortness of breath, and new agitation, paranoia, or hearing things others don't. Anything that feels like an emergency needs urgent medical care.

Keep a short log before your appointment: when you take the medicine, how you sleep, how much you eat, and any heart or mood symptoms. Your prescriber can use that record to judge what you're experiencing against the label.

Misuse risk, schedule II status, and signs to watch for

Neither drug is safe from misuse, but Vyvanse's label describes one feature that changes how it can be misused. The FDA prescribing information for both products carries the boxed warning about abuse, misuse, and addiction, and the DEA places both in schedule II. Vyvanse's label also notes that its prodrug design means the drug is less likely to produce an immediate effect when taken in unintended ways, though the label doesn't call it free of risk. Your prescriber can explain how that applies to your history.

A person's own history carries more weight than the product. If you or a family member has ever had a substance use disorder, tell your prescriber before any switch, because that history shapes how they weigh each option and how closely they follow up.

NIDA describes stimulant misuse as taking a medicine in a way or amount other than prescribed, taking someone else's prescription, or taking it to get high. Signs that use may be drifting that way include taking extra doses, running out of a prescription early, needing more to get the same effect, feeling unable to function or sleep without it, getting medicine from more than one prescriber, and going days with little sleep or food.

Noticing one of these doesn't mean you've done something wrong. It means the plan needs a conversation. Tell your prescriber plainly, since they'd rather adjust care than find out later.

If stimulant use has become hard to control, a licensed clinician can assess it without obligation. At Rize OC, that assessment weighs your physical and mental health, safety, home support, and daily responsibilities before recommending a level of care.

Why switching between the two is a prescriber decision

Moving from Adderall to Vyvanse, or the reverse, isn't a one-for-one swap, so the decision belongs with the person who prescribes your medicine. The two products contain different active ingredients and release them differently, and a milligram of one doesn't equal a milligram of the other. Dose conversions aren't something to look up or work out yourself, and the FDA labels don't offer a shortcut for it.

Your prescriber will usually start with your history. They'll look at how you've responded to your current medicine, which side effects have bothered you, your blood pressure and heart rate, your sleep, and any other prescriptions or supplements you take. They'll also ask about past or present substance use, because that affects which option they consider and how often they want to see you afterward.

Expect the change, if there is one, to come with a plan. That plan typically covers what to do with your current supply, how soon to check in, and which symptoms should prompt a call before your next visit. Your pharmacist can confirm how to take a new product and whether it interacts with anything else you use.

Stopping one stimulant and starting another on your own can leave you with unpredictable effects, so wait for instructions even if a friend or a forum describes an easy switch. Leftover tablets or capsules from an old prescription shouldn't be saved as a backup or shared with anyone, since taking medicine that wasn't prescribed to you counts as misuse under NIDA's definition above.

If your prescriber raises a switch, it's reasonable to ask what problem it's meant to solve. Sometimes the answer is timing, sometimes side effects, and sometimes it's a concern about misuse. Knowing the reason helps you judge how the change is going.

Questions to bring to your prescriber

Prescribers usually have about the length of one appointment to cover a medication change, so a handful of written questions will get you further than trying to remember everything in the room. Start with the one that frames the rest, which is whether they're comparing Vyvanse against immediate-release Adderall or against Adderall XR. From there, ask what they expect the switch to change for you, and how you'll both know whether it worked.

Then ask about the practical side. Find out how your current supply will be handled, when you should check in afterward, and which symptoms should prompt a call before your next visit. If you take other prescriptions or supplements, ask your prescriber or pharmacist whether any of them interact with the new product. Bring your sleep, appetite, and mood log so the answers rest on what you've actually noticed.

If you've had trouble with stimulants before, say so plainly and ask how your history changes their follow-up plan. That includes a past substance use disorder, a family history, or times you've taken more than prescribed. Those details help your prescriber choose, and they won't count against you.

Sometimes ADHD medication is only part of what's going on. If anxiety, depression, or substance use is mixed in, ask whether treatment for those should happen alongside the ADHD plan. At Rize OC, our dual diagnosis care treats mental health symptoms and substance use together in one plan, and medication decisions stay with a licensed prescriber. You can read more about ADHD care before you decide.

If you'd like to talk through next steps, call us at (949) 461-2620 or verify your insurance online. Benefits vary by plan, and we verify them before care starts.

About the Author

RO

Rize OC

Editorial Team

Helpful educational resources from Rize OC.

Share this article

Take the Next Step

You deserve
compassionate care.

If you or a loved one is struggling with addiction or mental health, the Rize OC team is here to help — confidentially and with no obligation.